Hcv ns3 protease inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/12 (2006.01)

Patent

CA 2606195

The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. I

L'invention concerne des composés macrocycliques représentés par la formule (I), utiles comme inhibiteurs de la protéase NS3 du virus de l'hépatite C (VHC), un procédé de synthèse de ces composés et l'utilisation de ceux-ci pour traiter ou prévenir des infections par le VHC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hcv ns3 protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hcv ns3 protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv ns3 protease inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1471556

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.